Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 2 Study of JZP-110 in Narcolepsy Patients with Excessive Sleepiness by Carolyn Helms | Apr 26, 2017 | Portfolio News
Jazz Pharmaceuticals Announces Positive Results from the Phase 2/3 EXPRESS Study of Xyrem in Pediatric Patients with Narcolepsy with Cataplexy by Carolyn Helms | Apr 24, 2017 | Portfolio News
Aimmune Therapeutics Appoints Eric Bjerkholt as Chief Financial Officer by Carolyn Helms | Apr 13, 2017 | Portfolio News
New Study Published in The American Journal of Medicine Expands the Clinical Evidence Underscoring the Value of the Corus® CAD Blood Test to Help Safely Direct Cardiovascular Care by Carolyn Helms | Apr 12, 2017 | Portfolio News
Tricida Announces Hiring of Geoffrey Parker as Chief Financial Officer and Senior Vice President by Carolyn Helms | Apr 11, 2017 | Portfolio News
